Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial
We performed a prospective, randomized, open-label equivalence study comparing the use of naproxen to aspirin in 33 patients with rheumatic fever. The mean time until resolution of arthritis was 2.9±2.9 days in both groups. Liver enzyme elevations were more frequent in the aspirin group (P=.002). We...
Saved in:
Published in | The Journal of pediatrics Vol. 143; no. 3; pp. 399 - 401 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Mosby, Inc
01.09.2003
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We performed a prospective, randomized, open-label equivalence study comparing the use of naproxen to aspirin in 33 patients with rheumatic fever. The mean time until resolution of arthritis was 2.9±2.9 days in both groups. Liver enzyme elevations were more frequent in the aspirin group (P=.002). We conclude that naproxen is as effective, is easier to use, and is safer than aspirin in the treatment of the arthritis of rheumatic fever. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-News-3 content type line 23 |
ISSN: | 0022-3476 1097-6833 |
DOI: | 10.1067/S0022-3476(03)00388-3 |